Blog

There’s a race to get 2 revolutionary new cancer treatments on the market — here’s who’s in the lead – Business Insider


Business Insider

There's a race to get 2 revolutionary new cancer treatments on the market — here's who's in the lead
Business Insider
Two cutting-edge treatments for blood cancers are poised to get approved by the end of the year. The highly personalized treatment is called CAR T-cell therapy. It's a type of cancer immunotherapy, or a therapy that harness the body's immune system to
How will Novartis price its groundbreaking CART med? R&D exec offers some cluesFiercePharma


Novartis' CART shows durable response in lymphoma patientsPharmaTimes
Novartis's Next Challenge: Pricing Breakthrough Cancer Treatment …Bloomberg

all 13 news articles »

2017-06-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.